Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROPI_POSTOP: Ropivacaine for Postoperative Pain in Endoscopic Sinonasal Surgery
NCT02821169Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- Apr 2015
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in postoperative pain, sponsored by CHU de Lille. Started Apr 2015; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02821169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02821169.